Logo

Harvard Bioscience Shares Slide 5.73 Percent on Lackluster Q4 Results

Mar 03, 2006

NEW YORK, March 3 (GenomeWeb News) - Shares in Harvard Bioscience were down 5.73 percent,or $.30, at $4.94 in afternoon trade after the company late yesterday reported marginal fourth-quarter revenue gains and a $8.9-million loss.

 

As GenomeWeb News reported this morning, the company posted a 2.4-percent increase in revenues to $7.8 million.

Breaking News
The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.